Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial - Concepedia

Concepedia

Publication | Closed Access

Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial

152

Citations

28

References

2021

Year

Thomas Bachelot, Thomas Filleron, Ivan Bièche, Mónica Arnedos, Mario Campone, Florence Dalenc, Florence Coussy, Marie‐Paule Sablin, Marc Debled, Claudia Lefeuvre‐Plesse,

Nature Medicine

Metastatic Breast CancerBreast OncologyMedicineImmunologyPathologyImmune Checkpoint InhibitorBreast CancerCancer TreatmentOncologyRadiation Oncology

References

	Year	Citations

Page 1

Page 1